bodies

18 bodies of drowned Afghans recovered at Iran border

HERAT, Afghanistan: Afghanistan has recovered 18 bodies of migrants who were allegedly beaten and tortured before being forced into a river by Iranian border guards last week, a senior Afghan official said Friday.Afghan authorities are investigating claims the migrants drowned while illegally...




bodies

18 bodies of drowned Afghans recovered at Iran border

HERAT, Afghanistan: Afghanistan has recovered 18 bodies of migrants who were allegedly beaten and tortured before being forced into a river by Iranian border guards last week, a senior Afghan official said on Friday.Afghan authorities are investigating claims the migrants drowned while illegally...




bodies

18 bodies of drowned Afghans recovered at Iran border

Afghanistan has recovered 18 bodies of migrants who were allegedly beaten and tortured before being forced into a river by Iranian border guards last week, a senior Afghan official said Friday.




bodies

Researchers Develop Quick Way to Create Human Antibodies

Title: Researchers Develop Quick Way to Create Human Antibodies
Category: Health News
Created: 5/1/2008 2:00:00 AM
Last Editorial Review: 5/1/2008 12:00:00 AM




bodies

Antibodies Found in Nearly All People Infected by New Coronavirus: Study

Title: Antibodies Found in Nearly All People Infected by New Coronavirus: Study
Category: Health News
Created: 5/8/2020 12:00:00 AM
Last Editorial Review: 5/8/2020 12:00:00 AM




bodies

Maternal Broadly Neutralizing Antibodies Can Select for Neutralization-Resistant, Infant-Transmitted/Founder HIV Variants

ABSTRACT

Each year, >180,000 infants become infected via mother-to-child transmission (MTCT) of HIV despite the availability of effective maternal antiretroviral treatments, underlining the need for a maternal HIV vaccine. We characterized 224 maternal HIV envelope (Env)-specific IgG monoclonal antibodies (MAbs) from seven nontransmitting and transmitting HIV-infected U.S. and Malawian mothers and examined their neutralization activities against nontransmitted autologous circulating viruses and infant-transmitted founder (infant-T/F) viruses. Only a small subset of maternal viruses, 3 of 72 (4%), were weakly neutralized by maternal linear V3 epitope-specific IgG MAbs, whereas 6 out of 6 (100%) infant-T/F viruses were neutralization resistant to these V3-specific IgG MAbs. We also show that maternal-plasma broadly neutralizing antibody (bNAb) responses targeting the V3 glycan supersite in a transmitting woman may have selected for an N332 V3 glycan neutralization-resistant infant-T/F virus. These data have important implications for bNAb-eliciting vaccines and passively administered bNAbs in the setting of MTCT.

IMPORTANCE Efforts to eliminate MTCT of HIV with antiretroviral therapy (ART) have met little success, with >180,000 infant infections each year worldwide. It is therefore likely that additional immunologic strategies that can synergize with ART will be required to eliminate MTCT of HIV. To this end, understanding the role of maternal HIV Env-specific IgG antibodies in the setting of MTCT is crucial. In this study, we found that maternal-plasma broadly neutralizing antibody (bNAb) responses can select for T/F viruses that initiate infection in infants. We propose that clinical trials testing the efficacy of single bNAb specificities should not include HIV-infected pregnant women, as a single bNAb might select for neutralization-resistant infant-T/F viruses.




bodies

Vaccine-Induced Th1-Type Response Protects against Invasive Group A Streptococcus Infection in the Absence of Opsonizing Antibodies

ABSTRACT

Recent global advocacy efforts have highlighted the importance of development of a vaccine against group A Streptococcus (GAS). Combo5 is a non-M protein-based vaccine that provides protection against GAS skin infection in mice and reduces the severity of pharyngitis in nonhuman primates. However, Combo5 with the addition of aluminum hydroxide (alum) as an adjuvant failed to protect against invasive GAS infection of mice. Here, we show that formulation of Combo5 with adjuvants containing saponin QS21 significantly improves protective efficacy, even though all 7 adjuvants tested generated high antigen-specific IgG antibody titers, including alum. Detailed characterization of Combo5 formulated with SMQ adjuvant, a squalene-in-water emulsion containing a TLR4 agonist and QS21, showed significant differences from the results obtained with alum in IgG subclasses generated following immunization, with an absence of GAS opsonizing antibodies. SMQ, but not alum, generated strong interleukin-6 (IL-6), gamma interferon (IFN-), and tumor necrosis alpha (TNF-α) responses. This work highlights the importance of adjuvant selection for non-M protein-based GAS vaccines to optimize immune responses and protective efficacy.

IMPORTANCE Availability of a group A Streptococcus vaccine remains an unmet public health need. Here, we tested different adjuvant formulations to improve the protective efficacy of non-M protein vaccine Combo5 in an invasive disease model. We show that novel adjuvants can dramatically shape the type of immune response developed following immunization with Combo5 and significantly improve protection. In addition, protection afforded by Combo5 is not mediated by opsonizing antibodies, believed to be the main correlate of protection against GAS infections. Overall, this report highlights the importance of adjuvant selection in raising protective immune responses against GAS invasive infection. Adjuvants that can provide a more balanced Th1/Th2-type response may be required to optimize protection of GAS vaccines, particularly those based on non-M protein antigens.




bodies

Neutralizing Monoclonal Antibodies against the Gn and the Gc of the Andes Virus Glycoprotein Spike Complex Protect from Virus Challenge in a Preclinical Hamster Model

ABSTRACT

Hantaviruses are the etiological agent of hemorrhagic fever with renal syndrome (HFRS) and hantavirus cardiopulmonary syndrome (HCPS). The latter is associated with case fatality rates ranging from 30% to 50%. HCPS cases are rare, with approximately 300 recorded annually in the Americas. Recently, an HCPS outbreak of unprecedented size has been occurring in and around Epuyén, in the southwestern Argentinian state of Chubut. Since November of 2018, at least 29 cases have been laboratory confirmed, and human-to-human transmission is suspected. Despite posing a significant threat to public health, no treatment or vaccine is available for hantaviral disease. Here, we describe an effort to identify, characterize, and develop neutralizing and protective antibodies against the glycoprotein complex (Gn and Gc) of Andes virus (ANDV), the causative agent of the Epuyén outbreak. Using murine hybridoma technology, we generated 19 distinct monoclonal antibodies (MAbs) against ANDV GnGc. When tested for neutralization against a recombinant vesicular stomatitis virus expressing the Andes glycoprotein (GP) (VSV-ANDV), 12 MAbs showed potent neutralization and 8 showed activity in an antibody-dependent cellular cytotoxicity reporter assay. Escape mutant analysis revealed that neutralizing MAbs targeted both the Gn and the Gc. Four MAbs that bound different epitopes were selected for preclinical studies and were found to be 100% protective against lethality in a Syrian hamster model of ANDV infection. These data suggest the existence of a wide array of neutralizing antibody epitopes on hantavirus GnGc with unique properties and mechanisms of action.

IMPORTANCE Infections with New World hantaviruses are associated with high case fatality rates, and no specific vaccine or treatment options exist. Furthermore, the biology of the hantaviral GnGc complex, its antigenicity, and its fusion machinery are poorly understood. Protective monoclonal antibodies against GnGc have the potential to be developed into therapeutics against hantaviral disease and are also great tools to elucidate the biology of the glycoprotein complex.




bodies

A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies

ABSTRACT

Recent outbreaks of yellow fever virus (YFV) in West Africa and Brazil resulted in rapid depletion of global vaccine emergency stockpiles and raised concerns about being unprepared against future YFV epidemics. Here we report that a live attenuated virus similar to the Japanese encephalitis virus (JEV) vaccine JE-CVax/Imojev that consists of YFV-17D vaccine from which the structural (prM/E) genes have been replaced with those of the JEV SA14-14-2 vaccine strain confers full protection in mice against lethal YFV challenge. In contrast to the YFV-17D-mediated protection against YFV, this protection is not mediated by neutralizing antibodies but correlates with YFV-specific nonneutralizing antibodies and T cell responses against cell-associated YFV NS1 and other YFV nonstructural (NS) proteins. Our findings reveal the potential of YFV NS proteins to mediate protection and demonstrate that chimeric flavivirus vaccines, such as Imojev, could confer protection against two flaviviruses. This dual protection may have implications for the possible off-label use of JE-CVax in case of emergency and vaccine shortage during YFV outbreaks. In addition, populations in Asia that have been vaccinated with Imojev may already be protected against YFV should outbreaks ever occur on that continent, as several countries/regions in the Asia-Pacific are vulnerable to international spread of the YFV.

IMPORTANCE Efficient and safe vaccines against yellow fever (e.g., YFV-17D) that provide long-lasting protection by rapidly inducing neutralizing antibody responses exist. However, the vaccine supply cannot cope with an increasing demand posed by urban outbreaks in recent years. Here we report that JE-CVax/Imojev, a YFV-17D-based chimeric Japanese encephalitis vaccine, also efficiently protects against YFV infection in mice. In case of shortage of the YFV vaccine during yellow fever outbreaks, (off-label) use of JE-CVax/Imojev may be considered. Moreover, wider use of JE-CVax/Imojev in Asia may lower the risk of the much-feared YFV spillover to the continent. More generally, chimeric vaccines that combine surface antigens and replication machineries of two distinct flaviviruses may be considered dual vaccines for the latter pathogen without induction of surface-specific antibodies. Following this rationale, novel flavivirus vaccines that do not hold a risk for antibody-dependent enhancement (ADE) of infection (inherent to current dengue vaccines and dengue vaccine candidates) could be designed.




bodies

Levodopa-induced dyskinesia in dementia with Lewy bodies and Parkinson disease with dementia

Objective

To investigate the frequency of levodopa-induced dyskinesia in dementia with Lewy bodies (DLBs) and Parkinson disease with dementia (PDD) and compare these frequencies with patients with incident Parkinson disease (PD) through a population-based cohort study.

Methods

We identified all patients with DLB, PDD, and PD without dementia in a 1991–2010 population-based parkinsonism-incident cohort, in Olmsted County, Minnesota. We abstracted information about levodopa-induced dyskinesia. We compared patients with DLB and PDD with dyskinesia with patients with PD from the same cohort.

Results

Levodopa use and dyskinesia data were available for 141/143 (98.6%) patients with a diagnosis of either DLB or PDD; 87 (61.7%), treated with levodopa. Dyskinesia was documented in 12.6% (8 DLB and 3 PDD) of levodopa-treated patients. Among these patients, median parkinsonism diagnosis age was 74 years (range: 64–80 years); 63.6%, male. The median interval from levodopa initiation to dyskinesia onset was 2 years (range: 3 months–4 years); the median daily levodopa dosage was 600 mg (range: 50–1,600 mg). Dyskinesia severity led to levodopa adjustments in 5 patients, and all improved. Patients with dyskinesia were diagnosed with parkinsonism at a significantly younger age compared with patients without dyskinesia (p < 0.001). Levodopa dosage was unrelated to increased risk of dyskinesias among DLB and PDD. In contrast, 30.1% of levodopa-treated patients with PD developed dyskinesia. In age-, sex-, and levodopa dosage–adjusted models, Patients with DLB and PDD each had lower odds of developing dyskinesia than patients with PD (odds ratio = 0.42, 95% CI 0.21–0.88; p = 0.02).

Conclusions

The dyskinesia risk for levodopa-treated patients with DLB or PDD was substantially less than for levodopa-treated patients with PD.




bodies

Recent Approaches To Optimize Laboratory Assessment of Antinuclear Antibodies [Minireviews]

The presence of antinuclear antibodies (ANAs) is a hallmark of a number of systemic autoimmune rheumatic diseases, and testing is usually performed as part of the initial diagnostic workup when suspicion of an underlying autoimmune disorder is high. The indirect immunofluorescence antibody (IFA) technique is the preferred method for detecting ANAs, as it demonstrates binding to specific intracellular structures within the cells, resulting in a number of staining patterns that are usually categorized based on the cellular components recognized and the degree of binding, as reflected by the fluorescence intensity or titer. As a screening tool, the ANA patterns can guide confirmatory testing useful in elucidating a specific clinical diagnosis or prognosis. However, routine use of ANA IFA testing as a global screening test is hampered by its labor-intensiveness, subjectivity, and limited diagnostic specificity, among other factors. This review focuses on current efforts to standardize the nomenclature of ANA patterns and on alternative methods for ANA determination, as well as on recent advances in image-based computer algorithms to automate IFA testing in clinical laboratories.




bodies

Development of an Extended-Specificity Multiplex Immunoassay for Detection of Streptococcus pneumoniae Serotype-Specific Antigen in Urine by Use of Human Monoclonal Antibodies [Diagnostic Laboratory Immunology]

Current pneumococcal vaccines cover the 10 to 23 most common serotypes of the 92 presently described. However, with the increased usage of pneumococcal-serotype-based vaccines, the risk of serotype replacement and an increase in disease caused by nonvaccine serotypes remains. Serotype surveillance of pneumococcal infections relies heavily on culture techniques, which are known to be insensitive, particularly in cases of noninvasive disease. Pneumococcal-serotype-specific urine assays offer an alternative method of serotyping for both invasive and noninvasive disease. However, the assays described previously cover mainly conjugate vaccine serotypes, give little information about circulating nonvaccine serotypes, and are currently available only in one or two specialist laboratories. Our laboratory has developed a Luminex-based extended-range antigen capture assay to detect pneumococcal-serotype-specific antigens in urine samples. The assay targets 24 distinct serotypes/serogroups plus the cell wall polysaccharide (CWP) and some cross-reactive serotypes. We report that the assay is capable of detecting all the targeted serotypes and the CWP at 0.1 ng/ml, while some serotypes are detected at concentrations as low as 0.3 pg/ml. The analytical serotype specificity was determined to be 98.4% using a panel of polysaccharide-negative urine specimens spiked with nonpneumococcal bacterial antigens. We also report clinical sensitivities of 96.2% and specificities of 89.9% established using a panel of urine specimens from patients diagnosed with community-acquired pneumonia or pneumococcal disease. This assay can be extended for testing other clinical samples and has the potential to greatly improve serotype-specific surveillance in the many cases of pneumococcal disease in which a culture is never obtained.




bodies

Identification of Novel Antigens Recognized by Serum Antibodies in Bovine Tuberculosis [Diagnostic Laboratory Immunology]

Bovine tuberculosis (TB), caused by Mycobacterium bovis, remains an important zoonotic disease posing a serious threat to livestock and wildlife. The current TB tests relying on cell-mediated and humoral immune responses in cattle have performance limitations. To identify new serodiagnostic markers of bovine TB, we screened a panel of 101 recombinant proteins, including 10 polyepitope fusions, by a multiantigen print immunoassay (MAPIA) with well-characterized serum samples serially collected from cattle with experimental or naturally acquired M. bovis infection. A novel set of 12 seroreactive antigens was established. Evaluation of selected proteins in the dual-path platform (DPP) assay showed that the highest diagnostic accuracy (~95%) was achieved with a cocktail of five best-performing antigens, thus demonstrating the potential for development of an improved and more practical serodiagnostic test for bovine TB.




bodies

High-Resolution Epitope Positioning of a Large Collection of Neutralizing and Nonneutralizing Single-Domain Antibodies on the Enzymatic and Binding Subunits of Ricin Toxin [Clinical Immunology]

We previously produced a heavy-chain-only antibody (Ab) VH domain (VHH)-displayed phage library from two alpacas that had been immunized with ricin toxoid and nontoxic mixtures of the enzymatic ricin toxin A subunit (RTA) and binding ricin toxin B subunit (RTB) (D. J. Vance, J. M. Tremblay, N. J. Mantis, and C. B. Shoemaker, J Biol Chem 288:36538–36547, 2013, https://doi.org/10.1074/jbc.M113.519207). Initial and subsequent screens of that library by direct enzyme-linked immunosorbent assay (ELISA) yielded more than two dozen unique RTA- and RTB-specific VHHs, including 10 whose structures were subsequently solved in complex with RTA. To generate a more complete antigenic map of ricin toxin and to define the epitopes associated with toxin-neutralizing activity, we subjected the VHH-displayed phage library to additional "pannings" on both receptor-bound ricin and antibody-captured ricin. We now report the full-length DNA sequences, binding affinities, and neutralizing activities of 68 unique VHHs: 31 against RTA, 33 against RTB, and 4 against ricin holotoxin. Epitope positioning was achieved through cross-competition ELISAs performed with a panel of monoclonal antibodies (MAbs) and verified, in some instances, with hydrogen-deuterium exchange mass spectrometry. The 68 VHHs grouped into more than 20 different competition bins. The RTA-specific VHHs with strong toxin-neutralizing activities were confined to bins that overlapped two previously identified neutralizing hot spots, termed clusters I and II. The four RTB-specific VHHs with potent toxin-neutralizing activity grouped within three adjacent bins situated at the RTA-RTB interface near cluster II. These results provide important insights into epitope interrelationships on the surface of ricin and delineate regions of vulnerability that can be exploited for the purpose of vaccine and therapeutic development.




bodies

Clinical and imaging features of children with autoimmune encephalitis and MOG antibodies

Objective

To describe the presentations, radiologic features, and outcomes of children with autoimmune encephalitis associated with myelin oligodendrocyte glycoprotein antibodies (MOG abs).

Methods

Identification of children fulfilling the diagnostic criteria for possible autoimmune encephalitis (AE) and testing positive for serum MOG abs. Chart review and comprehensive analysis of serum MOG abs using live cell assays and rat brain immunohistochemistry.

Results

Ten children (4 girls, 6 boys) with AE and serum MOG abs were identified. The median age at onset was 8.0 years (range: 4–16 years). Children presented with a combination of encephalopathy (10/10), headache (7/10), focal neurologic signs (7/10), or seizures (6/10). CSF pleocytosis was common (9/10, median 80 white cell count/μL, range: 21–256). Imaging showed cortical and deep gray matter involvement in all in addition to juxtacortical signal alterations in 6/10 children. No involvement of other white matter structures or contrast enhancement was noted. MOG abs were detected in all children (median titer 1:640; range: 1:320–1:10,540). Nine children had a favorable outcome at discharge (modified Rankin scale of < 2). Five of 10 children had up to 3 additional demyelinating relapses associated with persisting MOG abs. One child had NMDA receptor (NMDAR) abs at initial presentation. A second child had a third demyelinating episode with MOG abs with overlapping NMDAR encephalitis.

Discussion

AE associated with serum MOG abs represents a distinct form of autoantibody-mediated encephalitis in children. We therefore recommend including MOG abs testing in the workup of children with suspected AE.




bodies

Books: Pain and Prejudice: a Call to Arms for Women and Their Bodies




bodies

Antibacterial Monoclonal Antibodies Do Not Disrupt the Intestinal Microbiome or Its Function [Experimental Therapeutics]

Antibiotics revolutionized the treatment of infectious diseases; however, it is now clear that broad-spectrum antibiotics alter the composition and function of the host’s microbiome. The microbiome plays a key role in human health, and its perturbation is increasingly recognized as contributing to many human diseases. Widespread broad-spectrum antibiotic use has also resulted in the emergence of multidrug-resistant pathogens, spurring the development of pathogen-specific strategies such as monoclonal antibodies (MAbs) to combat bacterial infection. Not only are pathogen-specific approaches not expected to induce resistance in nontargeted bacteria, but they are hypothesized to have minimal impact on the gut microbiome. Here, we compare the effects of antibiotics, pathogen-specific MAbs, and their controls (saline or control IgG [c-IgG]) on the gut microbiome of 7-week-old, female, C57BL/6 mice. The magnitude of change in taxonomic abundance, bacterial diversity, and bacterial metabolites, including short-chain fatty acids (SCFA) and bile acids in the fecal pellets from mice treated with pathogen-specific MAbs, was no different from that with animals treated with saline or an IgG control. Conversely, dramatic changes were observed in the relative abundance, as well as alpha and beta diversity, of the fecal microbiome and bacterial metabolites in the feces of all antibiotic-treated mice. Taken together, these results indicate that pathogen-specific MAbs do not alter the fecal microbiome like broad-spectrum antibiotics and may represent a safer, more-targeted approach to antibacterial therapy.




bodies

Towards antibodies against COVID-19

Researchers have announced the isolation and characterization of a unique antibody that can bind to the virus that causes COVID-19 (SARS-CoV-2). The team has established that the antibody binds to a conserved epitope on the spike protein of SARS-CoV-2.




bodies

New York funeral home put bodies in trucks after running out of space

Police were called to a funeral home in New York after a bad smell coming from the street outside turned out to be from hundreds of bodies kept inside trucks.





bodies

Government to begin talks with Premier League and other sporting bodies to resume competition &apos;within weeks&apos;

The UK Government will this week begin a series of meetings with leading sports organisations with the hope of resuming competitions 'within weeks' after action was suspended by the coronavirus pandemic.




bodies

Atletico Madrid defender Renan Lodi tests positive for coronavirus while nine others show antibodies

Atletico Madrid defender Renan Lodi has tested positive for coronavirus, while nine other Rojiblancos players have shown antibodies of the virus.




bodies

Tennis governing bodies and Grand Slam tournaments create player relief program

The ATP, WTA, ITF and four Grand Slam events have created a program to support players affected by the sport's coronavirus-related shutdown.




bodies

A city of homebodies? How coronavirus will change Sydney

From washing hands to working from home, the coronavirus has dramatically altered city life. But will these changes last?




bodies

A city of homebodies? How coronavirus will change Sydney

From washing hands to working from home, the coronavirus has dramatically altered city life. But will these changes last?




bodies

A city of homebodies? How coronavirus will change Sydney

From washing hands to working from home, the coronavirus has dramatically altered city life. But will these changes last?




bodies

Two bodies found in Nepal search for missing Koreans

Kathmandu (AFP) April 26, 2020
Two bodies believed to be of South Koreans missing after being hit by a Himalayan avalanche in January have been found, officials said Sunday, a day after discovering the corpse of their Nepali guide. A wall of snow hit a trekking trail at about 3,230 metres (10,600 feet) near the Annapurna base camp in Nepal on January 17, burying four South Koreans and three locals. Avalanches and more




bodies

Search team finds bodies of all Koreans missing in Himalayan avalanche

Kathmandu (AFP) May 1, 2020
A search team on Friday recovered the last remaining two bodies missing after a Himalayan avalanche in January buried four South Korean trekkers and three locals. A wall of snow hit the trekkers at about 3,200 metres (10,500 feet) near the Annapurna base camp in Nepal on January 17, covering them under metres of snow. Avalanches and more snowfall since then made it too dangerous to lau




bodies

No more bodies on the streets. But coronavirus batters Ecuador with disproportionate force

Images of corpses in Ecuador stoked fear of the coronavirus' effect on developing nations. Infections have yet to peak elsewhere in Latin America.




bodies

Antibodies from llamas could help in fight against COVID-19

The hunt for an effective treatment for COVID-19 has led one team of researchers to find an improbable ally for their work: a llama named Winter. The team - from The University of Texas at Austin, the National Institutes of Health and Ghent University in Belgium - reports their findings about a potential avenue for a coronavirus treatment involving llamas on May 5 in the journal Cell.




bodies

Junshi, Eli Lilly Agree To Co-develop JS016 Antibodies Against COVID-19

Junshi Biosciences, a China-based biopharmaceutical company, and Eli Lilly and Company (LLY) have entered into an agreement to co-develop therapeutic antibodies for the potential prevention and treatment of COVID-19. Junshi SARS-CoV-2 Antibodies, or JS016, is a recombinant fully human monoclonal neutralizing antibody that is specific to the SARS-CoV-2 surface spike protein receptor binding domain. It is jointly developed by Junshi Biosciences and Institute of Microbiology, Chinese Academy of Science.




bodies

COVID-19: Lilly ramps up to beat the virus with neutralizing antibodies as scientists raise worries

Eli Lilly has teamed with China’s Junshi Biosciences in the U.S., marking the company's second COVID-19 pact to develop neutralizing antibodies against the virus. It promises to be a faster approach than designing a new small-molecule drug would be, but getting from idea to an effective product may not be so simple.




bodies

Multiple sclerosis: Autoantibodies target guardian lipids

Naturally occurring brain phospholipids that are targeted by autoantibodies in MS can suppress T-cell activity and ameliorate symptoms in a mouse model of the disease.




bodies

Extending therapeutic protein half-lives via fusion to affibodies with pH-dependent binding to neonatal Fc receptor

Fusing therapeutic proteins to affibodies with pH-dependent binding to neonatal Fc receptor could improve the proteins' half-lives.




bodies

Dead bodies are emerging from Mount Everest's melting glaciers

With a warming climate, the remains of unlucky mountaineers are beginning to rise from the ice.




bodies

Brooklyn townhouse retrofit embodies a “slow building” ethos

There are many special things about the home of Gennaro Brooks-Church, the director of the green building firm Eco Brooklyn.




bodies

Children's bodies contain alarming levels of plastic chemicals

A German study reveals that we're doing a poor job of keeping of safeguarding children's health when it comes to plastic.




bodies

Antibodies From a Llama Named Winter Could Help Scientists Find a Treatment For COVID-19

The hunt for an effective treatment for COVID-19 has led one team of researchers to find an improbable ally for their work: According to US and Belgian scientists, a four-year-old llama named Winter who lives in a secret location in Belgium could hold the key to a cure and help scientists find a treatment for COVID-19. The team — from The University of Texas at Austin, the National Institutes of Health and Ghent University in Belgium — reports their findings of a potential avenue for a coronavirus treatment involving llamas on May 5 in the journal Cell.





bodies

Mumbai: Offices to have 5 per cent attendance in MMR and 3 civic bodies

Maharashtra government's offices located in Mumbai Metropolitan Region (MMR), in areas of municipal corporations of Pune, Pimpri-Chinchwad and Malegaon in Nashik district will function with five per cent attendance during the lockdown period till May 17 to contain spread of coronavirus. The MMR and areas under PMC, PCMC and Malegaon Municipal Corporation (MMC) have emerged as the coronavirus hotspots. In a statement on Tuesday, the government also said that in the rest of Maharashtra, the attendance of officials of the rank of deputy secretary and above will be 100 per cent, while that of the other officials and staffers will be 33 per cent as per the requirement.

The government, however, said that offices of departments such as health and family welfare, police, jail, fire brigade and emergency services, disaster management, Food Corporation of India, Nehru Yuva Kendra, municipal services and others will remain functional with complete attendance. The statement also said that the government officials and staffers should download the 'Aarogya Setu' application on their smartphones and work according to the guidelines issued by the Centre.

The statement reiterated that those attending offices should take precautionary measures and maintain proper hygiene during the period to keep the novel coronavirus at bay.

Catch up on all the latest Mumbai news, crime news, current affairs, and a complete guide from food to things to do and events across Mumbai. Also download the new mid-day Android and iOS apps to get latest updates.

Mid-Day is now on Telegram. Click here to join our channel (@middayinfomedialtd) and stay updated with the latest news

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever




bodies

Mumbai: BJP slams BMC after hospital places COVID-19 patients with dead bodies

A video purportedly showing bodies of COVID-19 victims lying unattended near coronavirus patients at a civic-run hospital here has surfaced, following which a BJP MLA hit out at the Shiv Sena-ruled Brihanmumbai Municipal Corporation. Latching on to the video, BJP legislator Nitesh Rane said this shows the Brihanmumbai Municipal Corporation (BMC) does not pay attention to the safety of patients.

The video purportedly showed some bodies lying near COVID-19 patients undergoing treatment at the Lokmanya Tilak Municipal General Hospital in Sion area of Mumbai. Rane tagged the video in a tweet on the micro-blogging site on Wednesday night. "The Sion hospital has shown utmost negligence by letting COVID-19 patients sleep among the bodies of those who died of the same disease. The BMC boasts of being the richest civic body but pays no attention towards the safety of patients," the BJP leader said on Thursday.

He noted that the hospital in Sion mostly gets patients from Dharavi, the biggest slum area in the country. "Is this how we treat our working class? Such carelessness of the medical staff and the Sion hospital could result in further spread of coronavirus infection," he said. As the video stirred a controversy, the hospital's dean Dr Pramod Ingale said relatives of the those who died of COVID-19 are reluctant to take the bodies. "That is the reason why the bodies were kept there unattended. We have now removed the bodies and are probing the matter," he said.

Asked why the bodies were not shifted to a mortuary, Ingale said, "There are 15 slots in the hospitals mortuary of which 11 are already filled. If we shift all the bodies to the mortuary, it will be a problem for bodies of those who died of causes other than COVID-19." Till Wednesday, Mumbai reported 10,527 COVID-19 cases and 412 deaths.

Catch up on all the latest Mumbai news, crime news, current affairs, and a complete guide from food to things to do and events across Mumbai. Also download the new mid-day Android and iOS apps to get latest updates.

Mid-Day is now on Telegram. Click here to join our channel (@middayinfomedialtd) and stay updated with the latest news

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever




bodies

Madonna tested positive for COVID-19 antibodies

Pop diva Madonna has revealed that she has tested positive for the COVID-19 antibodies. The singer shared the news in the 14th edition of her 'Quarantine Diary' on Instagram TV.

"Took a test the other day and I found out that I have the antibodies. So tomorrow I'm just going to go for a long drive in the car, and I'm gonna roll down the window and I'm gonna breathe in the COVID-19 air. Yup. I hope the sun is shining," Madonna said.

According to Centers for Disease Control and Prevention (CDC), US, antibody tests are used to determine whether or not a person has been exposed to COVID-19 by finding proteins the body produces to fight the virus. However, the CDC has yet to confirm if the possession of antibodies is equal to immunity.

Catch up on all the latest entertainment news and gossip here. Also, download the new mid-day Android and iOS apps.

Mid-Day is now on Telegram. Click here to join our channel (@middayinfomedialtd) and stay updated with the latest news

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever




bodies

Investigating New Antibodies To Identify Individuals at Risk of Dengue

New information obtained using an original mathematical and statistical analysis method could help identify individuals at risk of dengue infection, according




bodies

Antibodies Could Effectively Treat OCD

OCD patients have increased levels of Immuno-moodulin (Imood) protein in their lymphocytes. Antibody that neutralized Imood, can reduce the level of anxiety,




bodies

De Novo Donor-specific Antibodies Linked to Blood Vessels Thickening After Kidney Transplant

After kidney transplant, kids who developed anti-human leukocyte antibodies against their donor kidney, known as de novo donor-specific antibodies (dnDSA)




bodies

Revenue bodies and banks move towards transparent compliance

Officials from revenue bodies, the banking sector and OECD met in Rome on 10-11 October to discuss ways to enhance the relationship between tax administrations and the banking industry and thus improve tax compliance.




bodies

United States Imports - Parts, Engines, Bodies & Chassis (Census Basis)

Imports - Parts, Engines, Bodies & Chassis (Census Basis) in the United States decreased to 11056.71 USD Million in March from 12912.79 USD Million in February of 2020. Imports - Parts, Engines, Bodies & Chassis (Census in the United States averaged 7138.70 USD Million from 1989 until 2020, reaching an all time high of 13619.06 USD Million in December of 2018 and a record low of 2199.39 USD Million in March of 1991. This page includes a chart with historical data for the United States Imports of Parts, Engines, Bodies & Chassis.




bodies

Scientists say 15% of Europeans could already be carrying antibodies for coronavirus

Scientists studying Gangelt, the town at the centre of Germany's first big outbreak discovered that as many as 15 per cent of people may have already acquired coronavirus immunity.




bodies

The last words Neil Filipowicz heard from his nephew were 'I'm not leaving Daddy' . . . then hours later he was pulling their bodies out of the basement locked arm in arm after Sandy snatched them away

John Filipowicz, 51, and his son John, 20, were found still holding onto each other in their basement as they shielded themselves from the torrent which covered them in 12ft of water in seconds. Relatives said that the two had an 'incredible bond' and would never have been separated – in life or in death. John the elder stayed behind to watch over his house in Staten Island, New York, but his son refused to leave because he wanted to be by his side.




bodies

Cher Lloyd embodies showgirl chic as she dons a plunging sequinned corset in her new music video

The singer, 26, sizzled in the music video for her latest single called Lost which was released on Friday.




bodies

The Crown's Josh O'Connor embodies Prince Charles as he films scene at the British Museum

Josh, 29, had his hair slicked back into Prince Charles' signature quiff, at one point sporting a number of hair clips as production crew tended to his outfit.